Biologics APIs

Apr 24, 2013
Pharmaceutical Technology
Because peptoids are relatively easy to synthesize, have tremendous sequence diversity, and are more proteolytically stable than peptides and proteins, they have significant potential for use as APIs, drug-delivery agents, and in numerous biomedical applications.
Mar 02, 2013
Pharmaceutical Technology
Growth is seen in outsourcing of insect- and plant-cell-based bioproduction expression systems.
Dec 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
As 2012 comes to a close, Pfizer leads among Big Pharma companies for FDA approvals of new molecular entities and biologics.
Aug 02, 2012
Pharmaceutical Technology
Budgets for biopharmaceutical activities are gaining in select functional areas except outsourcing.
May 02, 2011
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Approaches in using small-molecule and peptide synthesis offer promise in widening the scope of drug candidates.
Jan 07, 2011
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
Biologics are large molecular weight molecules primarily formulated for parenteral administration; however, there are some smaller biomolecules that have been formulated for oral use.
May 02, 2009
Pharmaceutical Technology
The organizations' presidents discuss market exclusivity, approval processes, and pending legislation.
Jun 02, 2008
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Nanoparticle-based systems present many advantages for the delivery of current and emerging biological drugs.
Jun 02, 2008
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Antibody drug conjugates offer a niche opportunity in drug development and contract manufacturing.
Dec 02, 2007
Pharmaceutical Technology
By Pharmaceutical Technology Editors
A surge in capacity in contract microbial and mammalian cell-culture is underway to meet rising production needs for biopharmaceuticals.
native1_300x100
lorem ipsum